This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishida, H. Articles by Carretero, O. A. Search for Related Content PubMed PubMed Citation Articles by Ishida, H. Articles by Carretero, O. A.

Hypertension, Vol 14, 322-327, Copyright © 1989 by American Heart Association

ARTICLES

Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins

H Ishida, AG Scicli and OA Carretero
Hypertension Research Division, Henry Ford Hospital, Detroit, Michigan 48202.

Arterial plasma kinins and mean arterial pressure were measured in intact and bilaterally nephrectomized rats infused with vehicle or bradykinin to study the role of 1) angiotensin converting enzyme (ACE) and other peptidases and 2) the kidney (a kininase-rich organ) in the metabolism of kinins in vivo. Before the infusion, rats were pretreated with vehicle, enalaprilat (an ACE inhibitor), or a cocktail of kininase inhibitors containing 1) enalaprilat, 2) DL-2-mercaptomethyl-3- guanidinoethyl-thiopropanoic acid (MGTA), a carboxypeptidase N inhibitor, 3) phosphoramidon, a neutral endopeptidase 24.11 inhibitor, and 4) bestatin, an aminopeptidase B inhibitor. In the rats with vehicle (n = 8), the cocktail did not significantly increase endogenous kinins (from 31 +/- 6 to 41 +/- 9 pg/ml, p = 0.94). In the rats infused with bradykinin (peptidase substrate), plasma kinins increased threefold in the group pretreated with the vehicle, 21-fold in the enalaprilat group, and 22-fold in the cocktail group. These increases were doubled by nephrectomy but were not affected by ureteral ligation. In the groups pretreated with the cocktail or enalaprilat, the hypotensive effect of bradykinin was correlated with plasma kinin concentration (r = 0.75, p less than 0.001). After bradykinin infusion was stopped, plasma kinins decreased by half in 10-12 seconds in the rats pretreated with vehicle, enalaprilat, or cocktail. We concluded that ACE and the kidney are important to the metabolism of circulating kinins while carboxypeptidase N, neutral endopeptidase 24.11 and aminopeptidase B are not. We also concluded that other tissue peptidases, not affected by either the above inhibitors or nephrectomy, play an important role in kinin metabolism.

This article has been cited by other articles:

				A. I. Smith, R. A. Lew, C. N. Shrimpton, R. G. Evans, and G. Abbenante A Novel Stable Inhibitor of Endopeptidases EC 3.4.24.15 and 3.4.24.16 Potentiates Bradykinin-Induced Hypotension Hypertension, February 1, 2000; 35(2): 626 - 630. [Abstract] [Full Text] [PDF]

				K.-S. Kim, S. Kumar, W. H. Simmons, and N. J. Brown Inhibition of Aminopeptidase P Potentiates Wheal Response to Bradykinin in Angiotensin-Converting Enzyme Inhibitor-Treated Humans J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 295 - 298. [Abstract] [Full Text]

				S.-I. Kitamura, L. A. Carbini, W. H. Simmons, and A. G. Scicli Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1664 - H1671. [Abstract] [Full Text] [PDF]

				W. R. Fitzgibbon, A. A. Jaffa, R. K. Mayfield, and D. W. Ploth Role of Kinins in the Renal Response to Enalaprilat in Normotensive and Hypertensive Rats Hypertension, February 1, 1996; 27(2): 235 - 244. [Abstract] [Full Text]